TEAVIGO™ (epigallocatechin gallate) supplementation prevents obesity in rodents by reducing adipose tissue mass

Annals of Nutrition and Metabolism

Volumn 49, Issue 1, 2005, Pages 54-63

  Wolfram, Swen ^a   Raederstorff, Daniel ^a   Wang, Ying ^a   Teixeira, Sandra R ^a   Elste, Volker ^a   Weber, Peter ^a  

^a DSM NUTRITIONAL PRODUCTS LTD   (Switzerland)

Author keywords

Adipose tissue; Catechin; Epigallocatechin gallate; Gene expression; Green tea; Obesity; Rodents; TEAVIGO

Indexed keywords

ACETYL COENZYME A CARBOXYLASE; EPIGALLOCATECHIN GALLATE; FATTY ACID SYNTHASE; GLUCOSE; LEPTIN; MESSENGER RNA; TEAVIGO; TRIACYLGLYCEROL; ANTIOBESITY AGENT; ANTIOXIDANT; CATECHIN; DRUG DERIVATIVE; FATTY ACID;

ADIPOCYTE; ADIPOSE TISSUE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; CELL DIFFERENTIATION; CONTROLLED STUDY; DIET SUPPLEMENTATION; DOSE RESPONSE; EPIDIDYMIS FAT; GENE EXPRESSION; GLUCOSE BLOOD LEVEL; LIPID METABOLISM; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; OBESITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RAT; SUBCUTANEOUS FAT; TRIACYLGLYCEROL BLOOD LEVEL; WEIGHT REDUCTION; ANIMAL; BLOOD; C57BL MOUSE; CHEMISTRY; DRUG EFFECT; GENE EXPRESSION REGULATION; GROWTH, DEVELOPMENT AND AGING; MALE; METABOLISM; RANDOMIZATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPRAGUE DAWLEY RAT; TEA;

RODENTIA;

ADIPOSE TISSUE; ANIMALS; ANTI-OBESITY AGENTS; ANTIOXIDANTS; BASE SEQUENCE; CATECHIN; DIETARY SUPPLEMENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; FATTY ACIDS; GENE EXPRESSION REGULATION; LEPTIN; MALE; MICE; MICE, INBRED C57BL; OBESITY; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TEA;

EID: 22844435525     PISSN: 02506807     EISSN: None     Source Type: Journal    
DOI: 10.1159/000084178     Document Type: Article

References (28)

1. Visscher TL, Seidell JC: The public health impact of obesity. Annu Rev Public Health 2001;22:355-375.
2. Flegal KM, Carroll MD, Ogden CL, Johnson CL: Prevalence and trends in obesity among US adults, 1999-2000. JAMA 2002;288:1723-1727.
3. Seidell JC: Prevalence and time trends of obesity in Europe. J Endocrinol Invest 2002;25:816-822.
4. Serrano Rios M: Relationship between obesity and the increased risk of major complications in non-insulin-dependent diabetes mellitus. Eur J Clin Invest 1998;28(suppl 2):14-18.
5. Goran MI, Ball GD, Cruz ML: Obesity and risk of type 2 diabetes and cardiovascular disease in children and adolescents. J Clin Endocrinol Metab 2003;88:1417-1427.
6. Allison DB, Fontaine KR, Manson JE, Stevens J, VanItallie TB: Annual deaths attributable to obesity in the United States. JAMA 1999;282:1530-1538.
7. Sheard NF: Moderate changes in weight and physical activity can prevent or delay the development of type 2 diabetes mellitus in susceptible individuals. Nutr Rev 2003;61:76-79.
8. Sartippour MR, Shao ZM, Heber D, Beatty P, Zhang L, Liu C, Ellis L, Liu W, Go VL, Brooks MN: Green tea inhibits vascular endothelial growth factor induction in human breast cancer cells. J Nutr 2002;132:2307-2311.
9. Kavanagh KT, Hafer LJ, Kim DW, Mann KK, Sherr DH, Rogers AE, Sonenshein GE: Green tea extracts decrease carcinogen-induced mammary tumor burden in rats and rate of breast cancer cell proliferation in culture. J Cell Biochem 2001;82:387-398.
10. Osada K, Takahashi M, Hoshina S, Nakamura M, Nakamura S, Sugano M: Tea catechins inhibit cholesterol oxidation accompanying oxidation of low density lipoprotein in vitro. Comp Biochem Physiol C Toxicol Pharmacol 2001;128:153-164.
11. Sano M, Tabata M, Suzuki M, Degawa M, Miyase T, Maeda-Yamamoto M: Simultaneous determination of twelve tea catechins by high-performance liquid chromatography with electrochemical detection. Analyst 2001;126:816-820.
12. Jung YD, Ellis LM: Inhibition of tumour invasion and angiogenesis by epigallocatechin gallate, a major component of green tea. Int J Exp Pathol 2001;82:309-316.
13. Sueoka N, Suganuma M, Sueoka E, Okabe S, Matsuyama S, Imai K, Nakachi K, Fujiki H: A new function of green tea: Prevention of life-style-related diseases. Ann NY Acad Sci 2001;928:274-280.
14. Dulloo AG, Duret C, Rohrer D, Girardier L, Mensi N, Fathi M, Chantre P, Vandermander J: Efficacy of a green tea extract rich in catechin polyphenols and caffeine in increasing 24-hour energy expenditure and fat oxidation in humans. Am J Clin Nutr 1999;70:1040-1045.
15. Rumpler W, Seale J, Clevidence B, Judd J, Wiley E, Yamamoto S, Komatsu T, Sawaki T, Ishikura Y, Hosoda K: Oolong tea increases metabolic rate and fat oxidation in men. J Nutr 2001;131:2848-2852.
16. Dulloo AG, Seydoux J, Girardier L, Chantre P, Vandermander J: Green tea and thermogenesis: Interactions between catechin-polyphenols, caffeine and sympathetic activity. Int J Obes Relat Metab Disord 2000;24:252-258.
17. Shimizu M, Kobayashi Y, Suzuki M, Satsu H, Miyamoto Y: Regulation of intestinal glucose transport by tea catechins. Biofactors 2000;13:61-65.
18. Matsumoto N, Ishigaki F, Ishigaki A, Iwashina H, Hara Y: Reduction of blood glucose levels by tea catechin. Biosci Biotechnol Biochem 1993;57:525-527.
19. Hara Y, Honda M: The inhibition of α-amylase by tea polyphenols. Agric Biol Chem 1990;54:1939-1946.
20. Kobayashi Y, Suzuki M, Satsu H, Arai S, Hara Y, Suzuki K, Miyamoto Y, Shimizu M: Green tea polyphenols inhibit the sodium-dependent glucose transporter of intestinal epithelial cells by a competitive mechanism. J Agric Food Chem 2000;48:5618-5623.
21. Juhel C, Armand M, Pafumi Y, Rosier C, Vandermander J, Lairon D: Green tea extract (AR25(R)) inhibits lipolysis of triglycerides in gastric and duodenal medium in vitro. J Nutr Biochem 2000;11:45-51.
22. Raederstorff DG, Schlachter MF, Elste V, Weber P: Effect of EGCG on lipid absorption and plasma lipid levels in rats. J Nutr Biochem 2003;14:326-332.
23. Kao YH, Hiipakka RA, Liao S: Modulation of endocrine systems and food intake by green tea epigallocatechin gallate. Endocrinology 2000;141:980-987.
24. Murase T, Nagasawa A, Suzuki J, Hase T, Tokimitsu I: Beneficial effects of tea catechins on diet-induced obesity: Stimulation of lipid catabolism in the liver. Int J Obes Relat Metab Disord 2002;26:1459-1464.
25. Chen L, Lee MJ, Li H, Yang CS: Absorption, distribution, elimination of tea polyphenols in rats. Drug Metab Dispos 1997;25:1045-1050.
26. Ullmann U, Haller J, Decourt JP, Girault N, Girault J, Richard-Caudron AS, Pineau B, Weber P: A single ascending dose study of epigallocatechin gallate in healthy volunteers. J Int Med Res 2003;31:88-101.
27. Abu Elheiga L, Oh W, Kordari P, Wakil Salih J: Acetyl-CoA carboxylase 2 mutant mice are protected against obesity and diabetes induced by high-fat/high-carbohydrate diets. Proc Natl Acad Sci USA 2003;100:10207-10212.
28. Ntambi JM, Miyazaki M, Stoehr JP, Lan H, Kendziorski CM, Yandell BS, Song Y, Cohen P, Friedman JM, Attie AD: Loss of stearoyl-CoA desaturase-1 function protects mice against adiposity. Proc Natl Acad Sci USA 2002;99:11482-11486.